Healthscope Ltd [ASX:HSO] has enjoyed a steady incline this morning, after the news rolled in of a new takeover approach.
The medical company, which operates private hospitals, medical centres and international pathology services, has received a proposal from Brookfield Capital Partners and its affiliates. They will be acquiring 100% of Healthscope in an off-market takeover offer.
The Healthscope share price hiked up 11% at $2.31 in morning trade.
If you’re interested in some other ASX plays with huge potential, check out our small-caps expert’s top picks here.
What’s the story?
Brookfield Capital Partners has made an offer representing a total value of $2.455 per share, and a simultaneous scheme of arrangement representing total value of $2.585 per share.
Under that scheme, shareholders potentially have the option to receive all cash or some of it in shares in another unlisted company controlled by Brookfield that would own 100% of Healthscope.
This has widely been considered an attractive proposal for shareholders, due to its certainty and superiority over other offers that have been made.
Is it time to invest in Healthscope?
Healthscope has had a difficult couple of years. Trading conditions have been tough, and so something like this is welcome news for the battered company.
Yet the offer is yet to result in a transaction, so shareholders have been advised not to take any action just yet. There are other great stocks in the healthcare sector at the moment that may be attractive to different types of investors. It could be wise to wait and see on this one, and take a look at those in the meantime.
Let’s stay abreast of any developments from here.
For Money Morning
PS: Are you investing in the right stocks? Top Aussie stock picker Sam Volkering has revealed four Aussie stocks he believes could be the top performers this year. Claim your free ‘The Four Best ASX Stocks for 2018’ report here.